As of November 2024, Kobayashi Pharmaceutical has a market cap of $2.83B. This makes Kobayashi Pharmaceutical the world's 4134th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $3.13B | -11.34% |
2023 | $3.53B | -24.81% |
2022 | $4.70B | -0.11% |
2021 | $4.70B | -28.31% |
2020 | $6.56B | 36.03% |
2019 | $4.82B | 24.10% |
2018 | $3.89B | 2.05% |
2017 | $3.81B | 46.40% |
2016 | $2.60B | 0.20% |
2015 | $2.60B | 41.76% |
2014 | $1.83B | 19.93% |
2013 | $1.53B | 43.17% |
2012 | $1.07B | 1.23% |
2011 | $1.05B | 7.43% |
2010 | $980.50M | 1.34% |
2009 | $967.50M | -3.12% |
2008 | $998.71M | -8.13% |
2007 | $1.09B | -5.86% |
2006 | $1.15B | 25.78% |
2005 | $918.08M | 27.67% |
2004 | $719.12M | 6.14% |
2003 | $677.51M | -3.76% |
2002 | $703.95M | -10.77% |
2001 | $788.91M | - |